{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:04:21Z","timestamp":1793826261956,"version":"4.6.1"},"reference-count":140,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Heart and Stroke Foundation of Ontario (HSFO)","id":[{"id":"https:\/\/ror.org\/00qbpyp73","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008572","name":"University of Ottawa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008572","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Ottawa Heart Institute Vered Chair in Cardiology","id":[{"id":"https:\/\/ror.org\/03c4mmv16","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Harry Perkins Institute of Medical Research, WA, Australia","id":[{"id":"https:\/\/ror.org\/02xz7d723","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.atherosclerosis.2018.07.014","type":"journal-article","created":{"date-parts":[[2018,7,25]],"date-time":"2018-07-25T05:23:55Z","timestamp":1532496235000},"page":"98-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":398,"special_numbering":"C","title":["Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions"],"prefix":"10.1016","volume":"276","author":[{"given":"Paolo","family":"Raggi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2248-9663","authenticated-orcid":false,"given":"Jacques","family":"Genest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon T.","family":"Giles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katey J.","family":"Rayner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Beanlands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib1","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1194\/jlr.R600009-JLR200","article-title":"Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy, part V: the discovery of the statins and the end of the controversy","volume":"47","author":"Steinberg","year":"2006","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJM197608122950707","article-title":"The pathogenesis of atherosclerosis (first of two parts)","volume":"295","author":"Ross","year":"1976","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib3","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/ATVBAHA.108.179705","article-title":"Inflammation in atherosclerosis","volume":"32","author":"Libby","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib4","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/01.ATV.15.5.551","article-title":"The response-to-retention hypothesis of early atherogenesis","volume":"15","author":"Williams","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib5","doi-asserted-by":"crossref","first-page":"13516","DOI":"10.1038\/ncomms13516","article-title":"Genome-wide RNAi screen reveals ALK1 mediates LDL uptake and transcytosis in endothelial cells","volume":"7","author":"Kraehling","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib6","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/cvr\/cvv218","article-title":"A\u00a0novel assay uncovers an unexpected role for SR-BI in LDL transcytosis","volume":"108","author":"Armstrong","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib7","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00041433-200210000-00003","article-title":"Sequestration of aggregated low-density lipoproteins by macrophages","volume":"13","author":"Kruth","year":"2002","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/CIRCRESAHA.110.223875","article-title":"Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity","volume":"108","author":"Miller","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib9","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/MOL.0000000000000217","article-title":"Atherogenic lipids and macrophage subsets","volume":"26","author":"Getz","year":"2015","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2013an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib11","first-page":"441","article-title":"Endothelial function and inflammation in coronary artery disease","volume":"92","author":"Tousoulis","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib12","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/nm1102-1211","article-title":"Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime","volume":"8","author":"Steinberg","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib13","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1161\/ATVBAHA.117.309123","article-title":"Scavenger receptor CD36 directs nonclassical monocyte patrolling along the endothelium during early atherogenesis","volume":"37","author":"Marcovecchio","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ni.1836","article-title":"CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer","volume":"11","author":"Stewart","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib15","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ni.2639","article-title":"CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation","volume":"14","author":"Sheedy","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib16","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib17","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/ni.2704","article-title":"Fatty acid-induced mitochondrial uncoupling elicits inflammasome-independent IL-1alpha and sterile vascular inflammation in atherosclerosis","volume":"14","author":"Freigang","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib18","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/ni.2711","article-title":"IL-1 signaling in atherosclerosis: sibling rivalry","volume":"14","author":"Sheedy","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib19","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1161\/ATVBAHA.111.224907","article-title":"Cell death, damage-associated molecular patterns, and sterile inflammation in cardiovascular disease","volume":"31","author":"Zheng","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib20","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2017.10.081","article-title":"Taming immune and inflammatory responses to treat atherosclerosis","volume":"71","author":"Libby","year":"2018","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1126\/scitranslmed.3006133","article-title":"Transforming growth factor-\u03b2 signaling in T cells promotes stabilization of atherosclerotic plaques through an interleukin-17-dependent pathway","volume":"5","author":"Gister\u00e5","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib22","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/cvr\/cvs115","article-title":"Smooth muscle cell phenotypic switching in atherosclerosis","volume":"95","author":"Gomez","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib23","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nm.3866","article-title":"KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis","volume":"21","author":"Shankman","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib24","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1161\/ATVBAHA.117.309229","article-title":"Cell death in the vessel wall: the good, the Bad, the Ugly","volume":"37","author":"Rayner","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib25","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cjca.2016.12.010","article-title":"Macrophage apoptosis and necrotic core development in atherosclerosis: a rapidly advancing field with clinical relevance to imaging and therapy","volume":"33","author":"Gonzalez","year":"2017","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib26","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/CIRCULATIONAHA.116.025684","article-title":"The Role of efferocytosis in atherosclerosis","volume":"135","author":"Kojima","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib27","doi-asserted-by":"crossref","first-page":"e1600224","DOI":"10.1126\/sciadv.1600224","article-title":"Targeting macrophage necroptosis for therapeutic and diagnostic interventions in atherosclerosis","volume":"2","author":"Karunakaran","year":"2016","journal-title":"Sci Adv"},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib28","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jacbts.2016.08.002","article-title":"The role of necroptosis in atherosclerotic disease","volume":"1","author":"Leeper","year":"2016","journal-title":"JACC Basic Transl Sci"},{"issue":"122","key":"10.1016\/j.atherosclerosis.2018.07.014_bib29","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/CIRCRESAHA.117.312115","article-title":"Somatic mutations and clonal hematopoiesis: unexpected potential new drivers of age-related cardiovascular disease","volume":"2","author":"Fuster","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib30","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib32","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1182\/blood-2011-11-394775","article-title":"Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer?","volume":"119","author":"Hasselbalch","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib33","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/ng.2700","article-title":"Association between large detectable clonal mosaicism and type 2 diabetes with vascular complications","volume":"45","author":"Bonnefond","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib34","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1126\/science.aag1381","article-title":"Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice","volume":"355","author":"Fuster","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib35","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.exphem.2017.08.001","article-title":"TET2 restrains inflammatory gene expression in macrophages","volume":"55","author":"Cull","year":"2017","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib36","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrcardio.2017.34","article-title":"Effects of dyslipidaemia on monocyte production and function in cardiovascular disease","volume":"14","author":"Rahman","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib37","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1161\/ATVBAHA.112.300134","article-title":"Cholesterol efflux: a novel regulator of myelopoiesis and atherogenesis","volume":"32","author":"Tall","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib38","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.cmet.2013.04.001","article-title":"Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis","volume":"17","author":"Nagareddy","year":"2013","journal-title":"Cell Metabol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib39","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1161\/ATVBAHA.114.303887","article-title":"Oxidized low-density lipoprotein induces long-term proinflammatory cytokine production and foam cell formation via epigenetic reprogramming of monocytes","author":"Bekkering","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib40","first-page":"425","article-title":"Increased haematopoietic activity in patients with atherosclerosis","volume":"38","author":"Valk","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib41","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1161\/01.ATV.0000143933.20616.1b","article-title":"Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein e knockout mice","volume":"24","author":"Branen","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.atherosclerosis.2004.11.016","article-title":"Disruption of tumor necrosis factor-alpha gene diminishes the development of atherosclerosis in apoe-deficient mice","volume":"180","author":"Ohta","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib43","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1161\/01.ATV.19.10.2364","article-title":"Interleukin-6 exacerbates early atherosclerosis in mice","volume":"19","author":"Huber","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib44","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.ATV.0000064374.15232.C3","article-title":"Lack of interleukin-1beta decreases the severity of atherosclerosis in apoe-deficient mice","volume":"23","author":"Kirii","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib45","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.4049\/jimmunol.163.3.1521","article-title":"Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis","volume":"163","author":"Charles","year":"1999","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3109\/03009749409095197","article-title":"Cytokines and acute phase proteins in rheumatoid arthritis","volume":"100","author":"Duff","year":"1994","journal-title":"Scand. J. Rheumatol. Suppl."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib47","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1161\/01.CIR.101.18.2149","article-title":"Elevation of tumor necrosis factor-{alpha} and increased risk of recurrent coronary events after myocardial infarction","volume":"101","author":"Ridker","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib48","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1161\/01.CIR.101.15.1767","article-title":"Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men","volume":"101","author":"Ridker","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib49","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/art.24092","article-title":"Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"59","author":"Avina-Zubieta","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib50","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1136\/annrheumdis-2011-200726","article-title":"Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"71","author":"Avina-Zubieta","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib51","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/acr.22173","article-title":"Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies","volume":"66","author":"Yurkovich","year":"2014","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib52","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/art.1780370408","article-title":"The mortality of rheumatoid arthritis","volume":"37","author":"Wolfe","year":"1994","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib53","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.semarthrit.2012.12.002","article-title":"The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: a systematic review","volume":"43","author":"Schoenfeld","year":"2013","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib54","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/oxfordjournals.aje.a009122","article-title":"Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study","volume":"145","author":"Manzi","year":"1997","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib55","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1161\/ATVBAHA.109.198424","article-title":"Rheumatic disease and carotid intima-media thickness: a systematic review and meta-analysis","volume":"30","author":"Tyrrell","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib56","doi-asserted-by":"crossref","first-page":"R36","DOI":"10.1186\/ar2641","article-title":"Coronary arterial calcification in rheumatoid arthritis: comparison to the multi-ethnic study of atherosclerosis","volume":"11","author":"Giles","year":"2009","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib57","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1002\/art.21288","article-title":"Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors","volume":"52","author":"Chung","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib58","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa035611","article-title":"Premature coronary-artery atherosclerosis in systemic lupus erythematosus","volume":"349","author":"Asanuma","year":"2003","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib59","first-page":"61","article-title":"Subclinical coronary artery calcification and relationship to disease duration in women with rheumatoid arthritis","volume":"35","author":"Kao","year":"2008","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib60","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1136\/annrheumdis-2013-203617","article-title":"Prevalence, extent and composition of coronary plaque in patients with rheumatoid arthritis without symptoms or prior diagnosis of coronary artery disease","volume":"73","author":"Karpouzas","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib61","first-page":"1789","article-title":"Novel cardiovascular risk factors in premature coronary atherosclerosis associated with systemic lupus erythematosus","volume":"35","author":"Rho","year":"2008","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib62","first-page":"937","article-title":"Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis","volume":"34","author":"Aubry","year":"2007","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib63","doi-asserted-by":"crossref","first-page":"R131","DOI":"10.1186\/ar3442","article-title":"Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study","volume":"13","author":"Innala","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib64","first-page":"2562","article-title":"Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset","volume":"26","author":"Wallberg-Jonsson","year":"1999","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib65","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1002\/art.30542","article-title":"Longitudinal predictors of progression of carotid atherosclerosis in rheumatoid arthritis","volume":"63","author":"Giles","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib66","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2174\/1874312901610010049","article-title":"Carotid artery atherosclerosis in patients with active rheumatoid arthritis: predictors of plaque occurrence and progression over 24 weeks","volume":"10","author":"Pope","year":"2016","journal-title":"Open Rheumatol. J."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib67","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/art.22418","article-title":"Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study","volume":"56","author":"Davis","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib68","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/art.38210","article-title":"Glucocorticoid dose thresholds associated with all-cause and cardiovascular mortality in rheumatoid arthritis","volume":"66","author":"del Rincon","year":"2014","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib69","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1002\/art.20661","article-title":"Effect of glucocorticoids on the arteries in rheumatoid arthritis","volume":"50","author":"del Rincon","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib70","first-page":"51","article-title":"Familial Mediterranean fever as an emerging clinical model of atherogenesis associated with low-grade inflammation","volume":"4","author":"Yuksel","year":"2010","journal-title":"Open Cardiovasc. Med. J."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib71","article-title":"Aortic, carotid intima-media thickness and flow- mediated dilation as markers of early atherosclerosis in a cohort of pediatric patients with rheumatic diseases","author":"Del Giudice","year":"2017","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib72","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12969-015-0061-5","article-title":"Premature subclinical atherosclerosis in children and young adults with juvenile idiopathic arthritis. A review considering preventive measures","volume":"14","author":"Bohr","year":"2016","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib73","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/annrheumdis-2014-206624","article-title":"The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis","volume":"74","author":"Roubille","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib74","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1136\/annrheumdis-2015-207870","article-title":"Comparative effects of biologics on cardiovascular risk among older patients with rheumatoid arthritis","volume":"75","author":"Zhang","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib75","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/art.40084","article-title":"Cardiovascular safety of tocilizumab versus tumor necrosis factor inhibitors in patients with rheumatoid arthritis: a multi-database cohort study","volume":"69","author":"Kim","year":"2017","journal-title":"Arthritis Rheum."},{"issue":"suppl 10","key":"10.1016\/j.atherosclerosis.2018.07.014_bib76","article-title":"Comparative cardiovascular safety of tocilizumab vs etanercept in rheumatoid arthritis: results of a randomized, parallel-group, multicenter, noninferiority, phase 4 clinical trial [abstract]","volume":"68","author":"Giles","year":"2016","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib77","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1002\/art.24040","article-title":"Atheroprotective effects of methotrexate on reverse cholesterol transport proteins and foam cell transformation in human thp-1 monocyte\/macrophages","volume":"58","author":"Reiss","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib78","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1002\/art.22809","volume":"56","author":"Dixon","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib79","first-page":"373","article-title":"Influence of anti-TNF-alpha infliximab therapy on adhesion molecules associated with atherogenesis in patients with rheumatoid arthritis","volume":"24","author":"Gonzalez-Gay","year":"2006","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib80","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/art.20407","article-title":"Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor alpha antibody","volume":"51","author":"Gonzalez-Juanatey","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib81","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1161\/01.CIR.0000037521.71373.44","article-title":"Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis","volume":"106","author":"Hurlimann","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib82","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1161\/CIRCULATIONAHA.112.120410","article-title":"Anti-tumor necrosis factor-alpha therapy reduces aortic inflammation and stiffness in patients with rheumatoid arthritis","volume":"126","author":"Maki-Petaja","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib83","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jacc.2015.11.037","article-title":"A\u00a0test in context: high-sensitivity c-reactive protein","volume":"67","author":"Ridker","year":"2016","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib84","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0140-6736(09)61717-7","article-title":"C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant metaanalysis","volume":"375","author":"Kaptoge","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib85","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa0807646","article-title":"JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib86","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1161\/01.CIR.0000015507.29953.38","article-title":"Elevated C reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies","volume":"105","author":"Burke","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib87","first-page":"1128","article-title":"Prognostic value of high-sensitivity C-reactive protein in a population of post-acute coronary syndrome patients receiving optimal medical treatment","volume":"19","author":"Riedel","year":"2012","journal-title":"Eur J PrevCardiol"},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib88","doi-asserted-by":"crossref","first-page":"e3011","DOI":"10.1371\/journal.pone.0003011","article-title":"The association of C-reactive protein and CRP genotype with coronary heart disease: findings from five studies with 4,610 cases amongst 18,637 participants","volume":"3","author":"Lawlor","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib89","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s11883-009-0020-z","article-title":"The role of C-reactive protein polymorphisms in inflammation and cardiovascular risk","volume":"11","author":"Hage","year":"2009","journal-title":"Curr. Atherosclerosis Rep."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib90","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0140-6736(12)60110-X","article-title":"The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis","volume":"379","author":"Holmes","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib91","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1161\/01.CIR.0000148135.08582.97","article-title":"Impact of interleukin-6 on plaque development and morphol- ogy in experimental atherosclerosis","volume":"110","author":"Schieffer","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib92","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1001\/jama.286.17.2107","article-title":"Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy","volume":"286","author":"Lindmark","year":"2001","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib93","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","article-title":"Interleukin-1 in the pathogenesis and treatment of inflammatory diseases","volume":"117","author":"Dinarello","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib94","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1161\/01.ATV.0000142812.03840.6f","article-title":"Chemokines: key regulators of mononuclear cell recruitment in atherosclerotic vascular disease","volume":"24","author":"Weber","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib95","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nri1733","article-title":"Monocyte and macrophage heterogeneity","volume":"5","author":"Gordon","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib96","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/eurheartj\/ehp308","article-title":"Monocyte heterogeneity in obesity and subclinical atherosclerosis","volume":"31","author":"Rogacev","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib97","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.atherosclerosis.2015.04.818","article-title":"Association of circulating levels of neopterin with non-culprit plaque vulnerability in CAD patients an angiogram, optical coherent tomography and intravascular ultrasound study","volume":"241","author":"Sun","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib98","doi-asserted-by":"crossref","first-page":"e2563","DOI":"10.1097\/MD.0000000000002563","article-title":"Level of pregnancy-associated plasma protein-a correlates with coronary thin-cap fibroatheroma burden in patients with coronary artery disease: novel findings from 3-vessel virtual histology intravascular ultrasound assessment","volume":"95","author":"Wu","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib99","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1161\/CIRCULATIONAHA.106.650846","article-title":"Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome","volume":"115","author":"Wollert","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib100","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.atherosclerosis.2017.03.031","article-title":"Galectin-3 binding protein, coronary artery disease and cardiovascular mortality: insights from the LURIC study","volume":"260","author":"Gleissner","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib101","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1056\/NEJMoa1107477","article-title":"C-reactive protein, fibrinogen, and cardiovascular disease prediction","volume":"367","author":"Kaptoge","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib102","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1086\/675988","article-title":"Pentraxin-3 and the right ventricle: the Multi-Ethnic Study of Atherosclerosis-right ventricle study","volume":"4","author":"Leary","year":"2014","journal-title":"Pulm. Circ."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib103","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.atherosclerosis.2016.02.013","article-title":"Relations of circulating GDF-15, soluble ST2, and troponin-I concentrations with vascular function in the community: the Framingham Heart Study","volume":"248","author":"Andersson","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib104","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1093\/eurheartj\/ehw147","article-title":"Imaging atherosclerosis with positron emission tomography","volume":"37","author":"Joseph","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2018.05.057","article-title":"[18F]-fluorodeoxyglucose PET\/CT imaging as a marker of carotid plaque inflammation: comparison to immunohistology and relationship to acuity of events","author":"Cocker","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib106","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1161\/01.CIR.0000020548.60110.76","article-title":"Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography","volume":"105","author":"Rudd","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib107","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.jacc.2006.05.076","article-title":"In\u00a0vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients","volume":"48","author":"Tawakol","year":"2006","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib108","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jcmg.2010.01.001","article-title":"18FDG PET and ultrasound echolucency in carotid artery plaques","volume":"3","author":"Graebe","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib109","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/CIRCIMAGING.110.959478","article-title":"Distribution of inflammation within carotid atherosclerotic plaques with high-risk morphological features: a comparison between positron emission tomography activity, plaque morphology, and histopathology","volume":"5","author":"Figueroa","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib110","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jcmg.2013.08.006","article-title":"Measurement of arterial activity on routine FDG PET\/CT images improves prediction of risk of future CV events","volume":"6","author":"Figueroa","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib111","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/ana.23553","article-title":"Carotid plaque inflammation on 18 F-fluorodeoxyglucose positron emission tomography predicts early stroke recurrence","volume":"71","author":"Marnane","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib112","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jacc.2013.04.066","article-title":"Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography\/computed tomography feasibility study","volume":"62","author":"Tawakol","year":"2013","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib113","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jcmg.2011.08.007","article-title":"Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes a prospective, randomized, comparator-controlled study using serial FDG PET\/CT imaging study of carotid artery and ascending aorta","volume":"4","author":"Mizoguchi","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib114","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.jacc.2017.01.060","article-title":"Detection of atherosclerotic inflammation by (68)Ga-DOTATATE PET compared to [(18)F]FDG PET imaging","volume":"69","author":"Tarkin","year":"2017","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib115","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1093\/eurheartj\/ehr367","article-title":"Imaging intraplaque inflammation in carotid atherosclerosis with 11C-PK11195 positron emission tomography\/computed tomography","volume":"33","author":"Gaemperli","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib116","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s12149-013-0757-x","article-title":"Feasibility and kinetic characteristics of (68)Ga-NOTA-RGD PET for in\u00a0vivo atherosclerosis imaging","volume":"27","author":"Paeng","year":"2013","journal-title":"Ann. Nucl. Med."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib117","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1161\/ATVBAHA.113.301710","article-title":"Molecular imaging reveals rapid reduction of endothelial activation in early atherosclerosis with apocynin independent of antioxidative properties","volume":"33","author":"Khanicheh","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib118","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/CIRCIMAGING.112.978932","article-title":"Cells and iron oxide nanoparticles on the move: magnetic resonance imaging of monocyte homing and myocardial inflammation in patients with ST-elevation myocardial infarction","volume":"5","author":"Sosnovik","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib119","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1161\/STROKEAHA.114.005163","article-title":"Volume of carotid artery ulceration as a predictor of cardiovascular events","volume":"45","author":"Kuk","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib120","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0140-6736(13)61754-7","article-title":"18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial","volume":"383","author":"Joshi","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib121","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.cjca.2012.09.017","article-title":"Atherosclerosis imaging and the Canadian atherosclerosis imaging network","volume":"29","author":"Tardif","year":"2013","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib122","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/hrt.2003.020180","article-title":"Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study","volume":"90","author":"Souverein","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib123","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1161\/CIRCULATIONAHA.113.004480","article-title":"Nonsteroidal anti-inflammatory drugs and the heart","volume":"129","author":"Patrono","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib124","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMoa1611593","article-title":"PRECISION Trial Investigators. Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis","volume":"375","author":"Nissen","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib125","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.jacc.2018.02.036","article-title":"Effect of aspirin coadministration on the safety of celecoxib, naproxen, or ibuprofen","volume":"71","author":"Reed","year":"2018","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib126","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(08)60763-1","article-title":"Aggressive reduction of inflammation stops events (ARISE) trial investigators. Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial","volume":"371","author":"Tardif","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib127","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1001\/jama.2013.282836","article-title":"VISTA-16 Investigators. Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial","volume":"311","author":"Nicholls","year":"2014","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib128","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1056\/NEJMoa1315878","article-title":"Darapladib for preventing ischemic events in stable coronary heart disease","volume":"370","author":"White","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib129","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/jama.2014.11061","article-title":"Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial","volume":"312","author":"O'Donoghue","year":"2014","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib130","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1016\/j.jacc.2013.03.003","article-title":"Effects of the P-selectin antagonist inclacumab on myocardial damage after percutaneous coronary intervention for non-ST-segment elevation myocardial infarction: results of the SELECT-ACS trial","volume":"61","author":"Tardif","year":"2013","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2018.07.014_bib131","article-title":"Effects of the P-Selectin antagonist inclacumab on myocardial damage after percutaneous coronary intervention according to timing of infusion: insights from the SELECT-ACS trial","volume":"5","author":"St\u00e4hli","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib132","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.amjcard.2014.11.003","article-title":"Comparative safety of interleukin-1 blockade with anakinra in patients with ST-segment elevation acute myocardial infarction (from the VCU-ART and VCU-ART2 pilot studies)","volume":"115","author":"Abbate","year":"2015","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib133","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jacc.2012.10.027","article-title":"Low-dose colchicine for secondary prevention of cardiovascular disease","volume":"61","author":"Nidorf","year":"2013","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib134","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/CIRCRESAHA.115.306656","article-title":"From C-reactive protein to interleukin-6 to interleukin-1: moving upstream to identify novel targets for atheroprotection","volume":"118","author":"Ridker","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib135","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"CANTOS Trial Group. Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib136","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0140-6736(17)32247-X","article-title":"CANTOS Trial Group. Effect of interleukin-1\u03b2 inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Ridker","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib137","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(17)32814-3","article-title":"CANTOS Trial Group. Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial","volume":"391","author":"Ridker","year":"2018","journal-title":"Lancet"},{"issue":"71","key":"10.1016\/j.atherosclerosis.2018.07.014_bib138","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1016\/j.jacc.2018.03.002","article-title":"Anti-inflammatory therapy with canakinumab for the prevention and management of diabetes","volume":"29","author":"Everett","year":"2018","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib139","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1016\/j.jacc.2018.03.490","article-title":"Inhibition of interleukin 1\u00df and cardiovascular outcomes in patients with chronic kidney disease","volume":"71","author":"Ridker","year":"2018","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.07.014_bib140","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1056\/NEJMc1714635","article-title":"Canakinumab for atherosclerotic disease","volume":"378","author":"Derlin","year":"2018","journal-title":"N.\u00a0Engl. J. Med."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915018312103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915018312103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T19:15:51Z","timestamp":1693768551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915018312103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":140,"alternative-id":["S0021915018312103"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.07.014","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}